Unicycive Therapeutics, Inc. Common Stock
$4.80
$0.03 (+0.63%)
$4.76Day Range$4.85
Key Statistics
Market Cap
$133.71M
Shares Outstanding
27.9M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jul 13, 2021
Round Lot
100
Locale
US
Trading Data
Day Open
$4.80
Day High
$4.85
Day Low
$4.76
Volume
1.11M
VWAP
$4.80
Prev Close
$4.77
Transactions
--
Acc. Volume
--
About Unicycive Therapeutics, Inc. Common Stock
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.
PHARMACEUTICAL PREPARATIONSSIC 283422 employees1975 W. EL CAMINO REAL, SUITE 204, MOUNTAIN VIEW, CA, 94040650-384-0642IPO Jul 13, 2021US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001766140
- Composite FIGI
- BBG01163JG34
- Share Class FIGI
- BBG01163JH05
- Ticker Root
- UNCY
- SIC Code
- 2834
About Unicycive Therapeutics, Inc. Common Stock (UNCY) Stock
Unicycive Therapeutics, Inc. Common Stock (UNCY) closed the 2026-09-18 session at $4.80, up 0.63% versus the previous close (+0.03). The stock opened at $4.80 and traded between $4.76 and $4.85 during that session. Session trading volume was 1.1M shares. The volume-weighted average price (VWAP) is $4.80.
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.
Unicycive Therapeutics, Inc. Common Stock has a market capitalization of $133.7 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. UNCY is listed on the XNAS exchange. The company employs approximately 22 people. Unicycive Therapeutics, Inc. Common Stock is headquartered in MOUNTAIN VIEW, CA. The recorded listing date is 2021-07-13.
On this page you can find market UNCY stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.